DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) has been given a consensus rating of “Hold” by the thirteen analysts that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $62.93.
Several research firms have recently issued reports on DOCU. JPMorgan Chase & Co. increased their price target on DocuSign from $48.00 to $50.00 in a research note on Friday, June 9th. UBS Group decreased their price target on DocuSign from $52.00 to $45.00 in a research note on Wednesday, May 31st. Piper Sandler increased their price objective on shares of DocuSign from $60.00 to $61.00 in a report on Friday, June 9th. Morgan Stanley decreased their price objective on shares of DocuSign from $54.00 to $49.00 in a report on Tuesday, June 27th. Finally, Citigroup decreased their price objective on shares of DocuSign from $80.00 to $73.00 in a report on Wednesday, June 7th.
DocuSign Trading Up 0.1 %
Shares of NASDAQ DOCU opened at $51.80 on Monday. DocuSign has a twelve month low of $39.57 and a twelve month high of $77.24. The company has a market capitalization of $10.48 billion, a price-to-earnings ratio of -148.00, a price-to-earnings-growth ratio of 11.25 and a beta of 0.91. The business has a 50 day simple moving average of $52.79 and a 200-day simple moving average of $55.97.
Insider Activity
In related news, Director Enrique T. Salem sold 2,500 shares of the company’s stock in a transaction dated Friday, July 7th. The shares were sold at an average price of $50.02, for a total value of $125,050.00. Following the sale, the director now owns 156,140 shares of the company’s stock, valued at $7,810,122.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other DocuSign news, insider Stephen Shute sold 100,315 shares of the company’s stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $49.20, for a total transaction of $4,935,498.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Enrique T. Salem sold 2,500 shares of the stock in a transaction on Friday, July 7th. The stock was sold at an average price of $50.02, for a total value of $125,050.00. Following the sale, the director now owns 156,140 shares in the company, valued at approximately $7,810,122.80. The disclosure for this sale can be found here. 17.80% of the stock is currently owned by company insiders.
Institutional Trading of DocuSign
Several large investors have recently made changes to their positions in DOCU. MetLife Investment Management LLC bought a new position in DocuSign in the first quarter valued at about $1,337,000. Raymond James Trust N.A. boosted its holdings in DocuSign by 27.3% during the first quarter. Raymond James Trust N.A. now owns 4,206 shares of the company’s stock worth $450,000 after buying an additional 901 shares during the last quarter. Sei Investments Co. boosted its holdings in DocuSign by 21.8% during the first quarter. Sei Investments Co. now owns 177,214 shares of the company’s stock worth $18,934,000 after buying an additional 31,769 shares during the last quarter. National Pension Service boosted its holdings in DocuSign by 25.9% during the first quarter. National Pension Service now owns 347,633 shares of the company’s stock worth $37,238,000 after buying an additional 71,449 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of DocuSign by 20.3% during the first quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company’s stock worth $1,854,127,000 after purchasing an additional 2,917,683 shares in the last quarter. Institutional investors own 76.03% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- Contrarian Play: Beyond Meat Is At An Inflection Point
- Alibaba Just Flashed Green, Very Green
- This Small Cap Stock Surged Over 100%
- The CPI Data Isn’t As Good As You Think It Is
- How to Invest in Gold and Silver
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.